Long Island Wealth Management’s Vanguard Intermediate-Term Corporate Bond ETF VCIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$500K Sell
6,048
-1,375
-19% -$115K 0.23% 56
2025
Q4
$622K Sell
7,423
-27
-0.4% -$2.27K 0.29% 52
2025
Q3
$627K Buy
7,450
+20
+0.3% +$1.66K 0.31% 52
2025
Q2
$616K Sell
7,430
-45,786
-86% -$3.72M 0.32% 52
2025
Q1
$4.35M Sell
53,216
-1,599
-3% -$129K 2.65% 15
2024
Q4
$4.4M Buy
54,815
+18,467
+51% +$1.51M 2.75% 12
2024
Q3
$3.04M Buy
+36,348
New +$2.99M 2% 17
2024
Q1
Sell
-1,323
Closed -$108K 385
2023
Q4
$108K Buy
+1,323
New +$102K 0.08% 93

Other funds holding VCIT

Long Island Wealth Management's VCIT Position: Q1 2026 in Review

Long Island Wealth Management reduced its Vanguard Intermediate-Term Corporate Bond ETF (VCIT) stake by 19% in Q1 2026, selling an estimated $115K and leaving 6,048 shares worth $500K. The position accounts for 0.23% of the portfolio, ranked #56.

Long Island Wealth Management first reported a position in VCIT in Q4 2023 and has held it in 8 quarters since. The position peaked at $4.4M in Q4 2024. 1,360 funds tracked by Wall St. Rank hold VCIT as of Q1 2026.

  • Long Island Wealth Management held 6,048 shares of Vanguard Intermediate-Term Corporate Bond ETF worth $500K as of Q1 2026.
  • Long Island Wealth Management sold 1,375 Vanguard Intermediate-Term Corporate Bond ETF shares in Q1 2026, an estimated $115K.
  • Vanguard Intermediate-Term Corporate Bond ETF made up 0.23% of Long Island Wealth Management's portfolio in Q1 2026, its #56 holding.
  • Long Island Wealth Management first reported a position in Vanguard Intermediate-Term Corporate Bond ETF in Q4 2023 and has held it in 8 quarters since.
  • Long Island Wealth Management's Vanguard Intermediate-Term Corporate Bond ETF position peaked at $4.4M in Q4 2024.
  • 1,360 funds tracked by Wall St. Rank held Vanguard Intermediate-Term Corporate Bond ETF as of Q1 2026.

Based on Long Island Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.